Janus kinase inhibitor provides long-term relief to adolescents with atopic dermatitis
Amy Paller of Northwestern University in Chicago and colleagues from seven countries analyzed long-term outcomes from three clinical trials and concluded that taking the Janus kinase (JAK) inhibitor upadacitinib…